We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
News & Events
NZYTech strengthens partnerships at Medlab Middle East 2023
Medlab Middle East is a renowned event that brings together key players in the laboratory and medical technology industry from all over the world. It's an opportunity for businesses to showcase their latest products and services, as well as meet with partners and explore new opportunities. This year, our CEO, Pedro Rio, attended the event, and it was an exciting opportunity to catch up with some of our valued partners.
One such partner is Biomss, a company that shares our passion for innovation and delivering exceptional products to the UAE. Our CEO had the pleasure of meeting with Sheila Adriano and Tayyab Shafi - MGM, who have been unwavering in their support of NZYTech. NZYTech and the Biomss team shared their latest updates, and it was inspiring to see the drive and enthusiasm for pushing the boundaries of life science research. We look forward to continuing this partnership and exploring new opportunities to deliver quality solutions. 
Another partnership that our CEO caught up with at Medlab Middle East was with Medical Masar Alshefaa (MMA). Together with NZYTech, they are committed to delivering superior molecular biology and clinical diagnostic solutions to the Kingdom of Saudi Arabia. It was an honor to catch up with Essam q. Subhi, Mohammed Dani, and Kareem Dorri at the event, and the discussions were centered around maintaining this partnership and driving growth and success together. We're excited to see what the future holds for this partnership and are committed to delivering quality solutions to the Kingdom of Saudi Arabia. NZYTech's attendance at Medlab Middle East reaffirmed the importance of partnerships in driving growth and success. We're grateful for the opportunity to have met with our valued partners and look forward to continuing to explore new opportunities together.